Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples